Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Cryptogenic Stroke clinical trials

2 of 2 indexed Cryptogenic Stroke trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Cryptogenic Stroke: 2 US clinical trials tracked, 2 recruiting.

Cryptogenic Stroke is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Recross Cardio, running 1 of these trials.

Enrollment posture brief

Registry condition cryptogenic-stroke

OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Cryptogenic Stroke (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Cryptogenic Stroke

Cryptogenic Stroke lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cryptogenic Stroke on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cryptogenic Stroke is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Recross Cardio 1 trials
Encore Medical 1 trials

Named interventions

Most-linked intervention names on Cryptogenic Stroke records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Recross P3 Occluder (P3O) System Device
1 trials
FDA-approved PFO closure device Device
1 trials
Encore PFO closure device Device
1 trials

US sites by state

Facility locations filed on Cryptogenic Stroke trials. A trial with sites in several states counts in each.

South Carolina 2 trials
Florida 2 trials
California 2 trials
New York 1 trials
Nebraska 1 trials
Mississippi 1 trials
Massachusetts 1 trials
Kansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cryptogenic Stroke page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Cryptogenic Stroke trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Recross Cardio sponsors the most Cryptogenic Stroke trials on record, review their full trial history before evaluating a specific study. See Recross Cardio's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cryptogenic Stroke condition card totals 2 registered trials; most-linked intervention Recross P3 Occluder (P3O) System; top US site state South Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.